MOSHKEVICH SOLOMON (PRESIDENT, CLINICALDIAGNOSTICS) sold 1.5% of their position (2.18K shares) of NATERA, INC. on the open market
Open‑market sale worth $445.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/30/2026ACC: 0002010019-26-000012
Officer· PRESIDENT, CLINICALDIAGNOSTICS
Since Feb 2026
-2.18K
Net shares
Net seller
$445.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.18K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−997.00
Price / share
$203.75
Trade value
$203.14K
% of position
0.7%
4/27/2026
147.88K→146.88K
Common Stock
Direct
Shares
−1.19K
Price / share
$204.39
Trade value
$242.20K
% of position
0.8%
4/27/2026
146.88K→145.70K
Total
Net shares
−2.18K
Net value
-$445.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/27/2026 | S · Sale | −997.00 | $203.75 | $203.14K | 0.7% | 147.88K | 146.88K |
| Common Stock Direct | 4/27/2026 | S · Sale | −1.19K | $204.39 | $242.20K | 0.8% | 146.88K | 145.70K |
| Total | −2.18K | -$445.34K | ||||||
Derivative Transactions0
No derivative transactions reported